Community Bank & Trust Waco Texas Has $390,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Community Bank & Trust Waco Texas reduced its stake in shares of Danaher Co. (NYSE:DHR) by 27.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,700 shares of the conglomerate’s stock after selling 650 shares during the period. Community Bank & Trust Waco Texas’ holdings in Danaher were worth $390,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of DHR. FMR LLC raised its holdings in Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after buying an additional 3,217,631 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in Danaher by 17.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after buying an additional 535,254 shares during the period. International Assets Investment Management LLC raised its holdings in Danaher by 40,196.5% during the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after buying an additional 428,897 shares during the period. Montrusco Bolton Investments Inc. raised its holdings in Danaher by 30.4% during the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after buying an additional 397,671 shares during the period. Finally, Union Bancaire Privee UBP SA acquired a new stake in Danaher during the 4th quarter worth approximately $74,551,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Down 1.6 %

DHR stock opened at $203.42 on Tuesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a fifty day moving average price of $232.72 and a two-hundred day moving average price of $251.61. Danaher Co. has a one year low of $203.00 and a one year high of $281.70. The stock has a market cap of $146.92 billion, a price-to-earnings ratio of 38.53, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 earnings per share. Equities analysts anticipate that Danaher Co. will post 7.67 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio is currently 20.45%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on DHR shares. Royal Bank of Canada reaffirmed an “outperform” rating and set a $277.00 price target (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Stifel Nicolaus raised their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Jefferies Financial Group decreased their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.